MindBio Therapeutics Begins Recruitment of Participants for World First LSD-Microdosing Clinical Trial in Cancer Patients Experiencing Emotional Distress

MindBio Therapeutics Corp. has recently started recruiting participants for an innovative clinical trial that combines LSD microdosing with Meaning Centred Psychotherapy to help cancer patients experiencing emotional distress. This groundbreaking trial aims to address the mental health needs of advanced stage cancer patients, making it the first of its kind in the world. &nbsp The Phase 2 trial ..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 26.
  • textsms

MindBio Therapeutics Begins Pre-Screening Participants for World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder

MindBio Therapeutics Corp. has started the pre-screening process to select participants for its Phase 2 clinical trial on LSD-Microdosing as a treatment for Major Depressive Disorder, making it the first time that take-home approvals have been given for LSD-Microdosing in a clinical trial. &nbsp The initial Phase 2a open-label trial will last for 8 weeks and aims to evaluate the effectiveness of..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 19.
  • textsms